Skip to main content
. 2019 Apr 30;35(2):100–106. doi: 10.3393/ac.2018.10.01

Fig. 1.

Fig. 1.

Recurrence-free survival according to pre-nCRT NLR using Kaplan-Meier analysis. Group with pre-CRT NLR >2.66 showed lower 5-year RFS (55.2% vs. 83.3%, P = 0.014). nCRT, neoadjuvant chemoradiation therapy; NLR, neutrophil to lymphocyte ratio; RFS, recurrence-free survival.